Amid deepening addiction crisis, FDA approves powerful new opioid

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approve...

Posted: Nov 5, 2018 2:06 AM
Updated: Nov 5, 2018 2:06 AM

Despite the ongoing opioid crisis plaguing the nation, the US Food and Drug Administration on Friday approved a new opioid medication five to 10 times more powerful than fentanyl.

Dsuvia, made by AcelRx Pharmaceuticals Inc., is a tablet in a single-dose, prefilled applicator to be administered under the tongue by health care providers to patients in settings such as hospitals, surgical centers and emergency rooms, according to the company.

Business and industry sectors

Business, economy and trade

Controlled substances

Drugs and society

Epidemics and outbreaks

Government organizations - US

Health and medical

Opioid epidemic

Opioids

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Prescription drug abuse

Public health

Society

Substance abuse

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

Drug overdoses

Medical treatments and procedures

Pain management

Consumer protection

Drug and medical devices approval

Pharmaceuticals and biotechnology regulation and policy

FDA Commissioner Dr. Scott Gottlieb was quick to defended the approval in a statement Friday: "The agency is taking new steps to more actively confront this crisis, while also paying careful attention to the needs of patients and physicians managing pain."

In April, Gottlieb told CNN Chief Medical Correspondent Dr. Sanjay Gupta that opioids are the biggest crisis facing the nation, a crisis fueled by overprescribing. The numbers say it all: More people die in the US each year from drug overdoses than from breast cancer.

Following the approval of Dsuvia, Gottlieb acknowledged that opioids are a unique class of medications. "I recognize that the debate goes beyond the characteristics of this particular product or the actions that we're taking to mitigate this drug's risks and preserve its differentiated benefits. We won't sidestep what I believe is the real underlying source of discontent among the critics of this approval -- the question of whether or not America needs another powerful opioid while in the throes of a massive crisis of addiction," he said.

But the criticism was quick. "The U.S. Food and Drug Administration (FDA) is recklessly and needlessly endangering people by approving a super-strong opioid," a statement from the public advocacy group Public Citizen said in response to the approval. The group noted that Dsuvia is five to 10 times more powerful than fentanyl and 1,000 times more potent than morphine.

"It is certain that Dsuvia will worsen the opioid epidemic and kill people needlessly," said Dr. Sidney Wolfe, founder and senior adviser of Public Citizen's Health Research Group.

"DSUVIA will not be available in retail pharmacies or for outpatient use. DSUVIA will only be distributed to health care settings certified in the DSUVIA Risk Evaluation and Mitigation Strategy (REMS) program following attestation by an authorized representative that the healthcare setting will comply with appropriate dispensing and use restrictions of DSUVIA," AcelRx said.

Other restrictions, according to the FDA, include that it cannot be used for more than 72 hours and will have the same black-box warnings as are required for all opioids about the risk of misuse and abuse that can lead to addiction and overdose death.

"Because of the risks of addiction, abuse and misuse with opioids; Dsuvia is also to be reserved for use in patients for whom alternative pain treatment options have not been tolerated, or are not expected to be tolerated, where existing treatment options have not provided adequate analgesia, or where these alternatives are not expected to provide adequate analgesia," according to a statement from Gottlieb about the drug's approval.

The statement noted the benefit the drug could have for soldiers injured on the battlefield. It notes that the Department of Defense was involved in its development and that it was a priority for the Pentagon because it "fills an unmet need."

The same drug, with the chemical name sufentanil, is already available as an IV medication. In its newly approved form, it is an option for patients with acute pain who are not able to receive an IV or are unable to swallow a pill. Dsuvia was approved by the European Medicines Agency in June under the name Dzuveo.

Dsuvia was rejected by an FDA advisory committee in 2017 because the committee wanted more data. AcelRx returned to the committee this year, and on October 12 the drug was recommended for approval. It is expected to be available in the first quarter of next year.

"As a single-dose, non-invasive medication with a rapid reduction in pain intensity, DSUVIA represents an important alternative for healthcare providers to offer patients for acute pain management," Dr. David Leiman, clinical assistant of surgery at University of Texas at Houston, said in a statement from AcelRx. Leiman was a researcher on an AcelRx study of Dsuvia in post-surgical patients.

Huntsville
Partly Cloudy
73° wxIcon
Hi: 81° Lo: 60°
Feels Like: 73°
Florence
Clear
° wxIcon
Hi: 81° Lo: 56°
Feels Like: °
Fayetteville
Partly Cloudy
75° wxIcon
Hi: 79° Lo: 55°
Feels Like: 75°
Decatur
Partly Cloudy
73° wxIcon
Hi: 81° Lo: 60°
Feels Like: 73°
Scottsboro
Clear
74° wxIcon
Hi: 79° Lo: 56°
Feels Like: 74°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

 

Alabama Coronavirus Cases

Cases: 540083

Reported Deaths: 11038
CountyCasesDeaths
Jefferson798481529
Mobile41283809
Madison35157506
Tuscaloosa25925455
Shelby25302249
Montgomery24723593
Baldwin21411310
Lee15993172
Calhoun14574319
Morgan14425280
Etowah13925353
Marshall12280225
Houston10648282
Elmore10158206
Limestone10070151
St. Clair9948245
Cullman9768194
Lauderdale9460243
DeKalb8865188
Talladega8341176
Walker7261278
Autauga7005108
Jackson6840112
Blount6773139
Colbert6322135
Coffee5581118
Dale4877113
Russell445738
Chilton4373113
Franklin426382
Covington4138118
Tallapoosa4044153
Escambia394877
Chambers3596123
Dallas3569153
Clarke351561
Marion3140101
Pike312077
Lawrence303098
Winston275873
Bibb264764
Geneva254178
Marengo249865
Pickens234862
Barbour232056
Hale224078
Butler219169
Fayette212862
Henry189943
Cherokee184845
Randolph182542
Monroe178141
Washington167839
Macon161350
Clay157257
Crenshaw153557
Cleburne149641
Lamar143336
Lowndes140653
Wilcox127430
Bullock123242
Conecuh110829
Coosa109228
Perry107826
Sumter105032
Greene92634
Choctaw61024
Out of AL00
Unassigned00

Tennessee Coronavirus Cases

Cases: 857055

Reported Deaths: 12312
CountyCasesDeaths
Shelby964521629
Davidson89674942
Knox51116636
Hamilton44570496
Rutherford43212437
Williamson28116217
Sumner24135349
Montgomery20402227
Wilson18907236
Out of TN1822399
Sullivan16952298
Unassigned16918134
Blount15559196
Bradley15100151
Washington14691245
Maury13545172
Sevier13451175
Putnam11437175
Madison11281241
Robertson9793132
Anderson8795171
Hamblen8632173
Greene7928156
Tipton7397104
Coffee6922123
Dickson6854113
Cumberland6769133
Carter6662158
Gibson6542146
McMinn654198
Bedford6522128
Roane6318105
Jefferson6244125
Loudon616469
Hawkins6161107
Lawrence598491
Monroe587596
Warren555581
Dyer5440106
Franklin516490
Fayette511878
Cheatham457856
Obion455096
Cocke452499
Lincoln437163
Rhea435775
Marshall420658
Campbell417463
Weakley416365
Giles4010100
Henderson380776
White368170
Carroll363483
Macon363178
Hardin358968
Hardeman353764
Henry320676
Lauderdale320244
Claiborne318873
Scott315245
Marion312847
Overton302561
Wayne297034
Hickman284746
McNairy284254
DeKalb280754
Smith278539
Haywood271562
Grainger263550
Morgan251339
Trousdale250622
Fentress243047
Johnson241939
Bledsoe215811
Chester215451
Polk208725
Unicoi204549
Crockett203549
Cannon192831
Union192234
Humphreys181528
Grundy179534
Sequatchie171829
Lake170526
Benton167340
Decatur159339
Lewis158426
Meigs139125
Stewart133028
Jackson132336
Clay110330
Houston109733
Perry107228
Moore101717
Van Buren85523
Pickett75924
Hancock59312

Community Events